GASS Clozapine

We want to decrease the mortality in people diagnosed with schizophrenia.

In this project, we will translate and validate a screening tool to detect clozapine side effects for clinical.

The NEMEA group in Spain set the main challenges in clozapine treatment, deciding that a better monitoring of clozapine side effects was a major goal. We then decided which characteristics should that scale cover, deciding that a modified version of GASS-C would fit all the requirements.

We are now embarking in the translation and validation into several languages, aiming to create an international cohort.